← Back to Search

Mindfulness for Caregiver Burden

N/A
Recruiting
Led By Ellen Langer, PhD
Research Sponsored by Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks, 3 months, 6 months after joining
Awards & highlights

Study Summary

This trial aims to develop an online community for people with ALS and their caregivers to improve their quality of life. The intervention includes a three-week program with cognitive exercises and videos to increase mindfulness, as well

Who is the study for?
This trial is for people with ALS and their primary caregivers. Patients must meet specific criteria for ALS diagnosis and be able to use technology like smartphones or computers with internet access. Caregivers should live with the patient, provide most of the unpaid care, and also be tech-savvy.Check my eligibility
What is being tested?
The study tests a 'mindful community' online platform aimed at improving quality of life through mindfulness practices. It includes a three-week e-learning program followed by ongoing participation in an online social forum designed to reinforce mindfulness habits.See study design
What are the potential side effects?
Since this intervention involves psychological support through mindfulness training rather than medication, traditional physical side effects are not expected. Participants may experience emotional discomfort as they engage in self-reflection.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks, 3 months, 6 months after joining
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks, 3 months, 6 months after joining for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amyotrophic Lateral Sclerosis
World Health Organization Quality of Life (Brief) WHO-QoL BREF - For Caregivers of PALS
Secondary outcome measures
ALS Specific QOL Short Form Quality of Life (ALSSQOL-SF)
Functional Status
Hospital Anxiety and Depression Scale (HADS)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MindfulnessExperimental Treatment1 Intervention
Three-week online mindfulness course followed by one-month social community online interaction.
Group II: Mindful LearningActive Control1 Intervention
Three-week online mindful learning course followed by one-month social community online interaction
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness
2014
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

Harvard UniversityLead Sponsor
229 Previous Clinical Trials
474,205 Total Patients Enrolled
1 Trials studying Caregiver Burden
28 Patients Enrolled for Caregiver Burden
Catholic University of the Sacred HeartOTHER
292 Previous Clinical Trials
203,787 Total Patients Enrolled
Ellen Langer, PhDPrincipal InvestigatorHarvard U
3 Previous Clinical Trials
560 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing efforts to enroll patients in this current medical study?

"As per the information available on clinicaltrials.gov, this clinical trial is currently accepting participants. The initial posting date for the trial was October 12th, 2023, and it was last updated on January 13th, 2024."

Answered by AI

What is the total number of participants being recruited for this research endeavor?

"Indeed, the details provided on clinicaltrials.gov indicate that this particular study is actively seeking eligible participants. The trial was initially posted on October 12th, 2023 and underwent its most recent update on January 13th, 2024. It aims to enroll a total of 300 individuals from a single location."

Answered by AI
~43 spots leftby Jun 2024